Member Info for TWatcher

"It doesn't say anything about the ABC19 test."

Exactly, you were wittering on "Remember the investors presentation? 3 countries are already waiting with orders", in response to the RNS and demanding people read the RNS properly, when that section of the presentation was about the ANTIBODY test not the ANTIGEN test. You were factually incorrect, the presentation did not say that 3 countries were waiting with orders in relation to the ANTIGEN test, either misunderstanding the presentation/RNS or deliberately mis-informing this board.

And you won't admit it.

I note you've abandoned that thread altogether, like many in life, just completely ignore when you've been called/caught out, like it never happened.

Nice way to confirm that your previous post that told everyone to read the RNS properly, was in fact based on you reading the RNS incorrectly.

"Remember the investors presentation? 3 countries are already waiting with orders and many more have already expressed an interest. "

The part of the investor presentation that mentioned 3 countries was in relation to the antibody test, not the antigen test.

"We still have those 7-8 tier one customer countries that we are targeting.... in terms of near term demand there are probably 3 countries who we are just waiting on final registrations to go thru, once their complete there is the expectation that the demand will come and it will be significant demand from these countries from what we are led to believe."

Nowhere else in the presentation is here a reference to 3 countries. So this RNS today has literally NOTHING to do with that part of the investor presentation.

And you are telling people to read the RNS properly ?

but very factually correct,13th of July predicted study completion and submission to occur in 2 weeks time, actually took 8 weeks.

ODX has very consistently been unable to predict timelines, in this case miscalculating a 2 week timeline into an 8 week timeline.

D. Evans did say on advfn just last week "we are still being subject to ODX's form of Chinese water torture"

All facts. None very appealing, I'll agree. Perhaps everyone would be better off with just the nice rosy facts, in which case stick with BJ, he reported 4 words from Mr Evans, but not a paragraph some 5 days previous that was much more informative.

Well, its progress, so has to be welcomed, but like with everything related to ODX, it's always baby steps, and it's significantly later that the expectation the company set.

On the 13th of July it was " We plan to submit the data from the study to our European Notified Body by the end of the month". So planning submission of the data from the study would occur in 2 weeks time.

Today we are told that the submission has now taken place and that "the conclusion of the Ulster study was the final step in this process".

So what was being predicted to occur in 2 weeks times on the 13th of July, has actually taken 8 weeks. Even this tiny movement of progress took x4 longer than predicted. This is a perfect microcosm of ODX entire performance this year, the ability to totally miscalculate timelines, even for minor steps, that are supposed to be only a couple of weeks away. Either than or they are just constantly happen to feed shareholders faff that can always be explained away later.

I like that phrase that was used by David Evans on the 2st of Sept on Advn. This is the guy that Bigjock36 has mentioned previously, a former director and someone who has 4M+ shares,which is still right on the money:-

" we are still being subject to ODX's form of Chinese water torture"

Why BJ36 decided not to report that particular quote, you'd need to ask him.

its all on record here on LSE, every post anyone every made.

Think I'll go look at the various things that were said about Innova being withdrawn.

because you took it up with me, but I didn't say it, Bigjock, he who has the ear of the CEO, said it, as per the first post of this thread.

Gman753
"TWatcher why would you think anything would happen over August in the EU. Its basically shut for the holiday - France especially."

I didn't but I'm sure you took it up with Bigjock who stated it as fact.

if someone seriously thinks ABDX planning is so s*it poor that they've churned out stock without a target for so much of it that they are desperate for twitter distributors they are in airy fairy land. We haven't even had 1 notified sales order !

the most obvious answer is that they have little interest in the product from their existing network. I did note at the time that ABDX's results had no 'imminent' timeline for sales, and in fact was in stark contrast to CK's comments on the short term situation. ABD is the lead member of the consortium.

I clearly remember many of the 'serious investors' here telling us that ODX was knocking out 100Ks a week of RTC-test continuously. With no notified sales, and hence no significant volume at distributors never mind those distributors getting their own sales, anything made back in Jan/Feb time must be getting pretty close to be getting hard to shift with the remaining shelf life.

So abdx, the entity that has sole responsibility for garner sales of the ABC-19 test, is reduced to advertising on twitter ? At this stage, after the test being available to the world since mid Feb 2021, and apparently on the case since before then, if any reputable distributor isn't aware of this test, what the hell have the salesforce been doing ?? where is the network and relationship building with distributors. All they should be doing now is filling in the minnows, having all the majors signed up. The reality is, not a single significant sales order, and shotgunning on twitter.

And where are these imminent sales that we were told about in the July ODX presentation, that everyone got so upbeat about ?

'soon' (regarding the gov contract, tweet in march), 'imminent'(regarding RTC sales in July results), we need to get access to the ODX dictionary, as they clearly have different definitions than the rest of us.

22 recommends, just shows that there are many here that'll vote up any old dross, even when the author confirms its a fantasy, but its the right fantasy for some.

ODX never specified a timeline, just what THEY not the body, was targeting. The ramp was to use the word anticipating, which implies a sense of expectation that was not suggested by the company. And then to just drop the phrase altogether, and just factual state "EU at home use approval in July/august also."

Filling in the DOB section of facebook seems to be the preferred way that those so inclined fulfil the need to be bestowed with birthday greetings from randoms.

But I guess one get ones kicks where one can.

EU approval of visitect and the ever changing "facts" of Bigjock36

8th July
"Processing CE Mark to sell Visitect in Europe for home use whereby Omega anticipate approval by the end of July"
stated as an unconditional fact. ODX NEVER used the word anticipated.

10th July
"Omega are also anticipating Self test approval in the EU (by the end of this month)"
I pointed out at the time that the phrase used by ODX was targetting, not anticipating, which of course was shouted down.

15th July
"EU at home use approval in July/august also."
the date starts to change.

1st of Aug
"At home approval EU approval also is being worked on"
Its august, and this time he doesn't bother to mention a timeframe. it's just being worked on.

11th of Aug
"EUA home use approval to come (countries like Germany they test multiple times per week)."
It's now coming, a bit like Christmas.

6 further posts by BJ since the 11th, not a peep about EU approval now, no sense of questioning why its late by his own recorded remarks. No sense of disappointment, it's more a case of "just forget I ever said the company was anticipating end of july (they never were), I've moved on to other better ramping targets"

All the dates of the posts are all there to allow verification, the great thing about LSE is that everyones posts are archived forever, without the possibility of editing. No ability to revise history.

And just to be crystal clear the company NEVER used the word anticipating in relation EU approval.

For those with short memories

it is interesting that the surescreen antigen test appeared in the MHRA field safety notices list covering 2-6 aug.

https://www.gov.uk/drug-device-alerts/field-safety-notices-2-to-6-august-2021
Reading the actual notice (date 29th july) it says that the intended use of the test was extended from professional use to "assisted use" and also for use in asymptomatic individuals. It goes on to say that is a change from the original requested use which was professional only and for people with symptoms.

The field safety notice looks like its a paper pushing exercise, with no actual changes required. But interesting that I had thought all tests being procured under the DPS where suppose to be self-test compatible. It appears the original use for the surescreen tests was for professional only use ?

I note that there are entries in the MHRA eua list for Magnifeye, separately a version for the innova test (DHSC test) and the orient gene test.

Magnifeye is an app produced by sensyne health that uses deep learning to detect faint lines that humans might miss. It just needs to be trained to analyse a particular cassette / line layout. So I assume as each HMG test gets selected, a variant of this app will roll out.

It's inconsistent therefore that there is no variation listed for the surescreen LFT. Does this suggest that surescreen tests are being used in different settings than the other two ? we know surescreen are supplying as we can see the monthly payments, but has anyone actually seen a surescreen test being provided / administered ?

biosuretest.com

Believe what the ceo has said, or believe some join the dot stuff.

Omega Diagnostics Group PLC said Friday that its technology partner has requested an emergency use authorization from the U.S. Food and Drug Administration for its rapid Covid-19 antigen test.

The medical-diagnostics company said the test will be used under both the Omega's Visitect brand and the Global Access Diagnostics brand.

The company's technology partner that filed submission to the FDA is Mologic Ltd.

"We are very pleased that the regulatory process to make our Visitect Covid-19 antigen test available in the U.S. professional use is progressing well," Chief Executive Colin King said.